Screener
Elevance Health ELV CarelonRx — Reportable segments’ operating gain
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elevance Health in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Elevance Health’s 10-Q, filed July 15, 2026.
- Filed
- Jul 15, 2026, 11:27 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001156039-26-000060
| Three Months Ended June 30, 2026 | Health Benefits / Three Months Ended June 30, 2026 | Carelon / Carelon Rx | Carelon / Carelon Services | Carelon / Total | Corporate & Other | Eliminations | Total |
|---|---|---|---|---|---|---|---|
| Benefit expense | $36,739 | — | $6,743 | $6,743 | $6 | $(6,464) | $37,024 |
| Cost of products sold | — | 10,473 | — | 10,473 | — | (4,981) | 5,492 |
| Operating expense | 5,085 | 195 | 866 | 1,061 | 81 | (680) | 5,547 |
| Operating gain (loss) | $896 | $582 | $366 | $948 | $(81) | — | $1,763 |
| Three Months Ended June 30, 2025 | |||||||
| Premiums | $39,710 | — | $1,863 | $1,863 | — | $(302) | $41,271 |
| Product revenue | — | 6,042 | — | 6,042 | — | — | 6,042 |
| Service fees | 1,872 | 4 | 232 | 236 | — | — | 2,108 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elevance Health's carelonrx — reportable segments’ operating gain?
- Elevance Health (ELV) reported carelonrx — reportable segments’ operating gain of $582M in Q2 2026.
- How has Elevance Health's carelonrx — reportable segments’ operating gain changed year-over-year?
- Elevance Health's carelonrx — reportable segments’ operating gain increased by 8.6% year-over-year, from $536M to $582M.
- What is the long-term trend for Elevance Health's carelonrx — reportable segments’ operating gain?
- Over 4 years (2021 to 2025), Elevance Health's carelonrx — reportable segments’ operating gain has grown at a 9.5% compound annual growth rate (CAGR), from $1.68B to $2.42B.
- What does carelonrx — reportable segments’ operating gain mean?
- The operating profit generated by the CarelonRx segment, calculated as total operating revenue minus benefit expenses, product costs, and operating expenses. This metric represents the core profitability of the pharmacy services business before interest, taxes, and corporate allocations. It is the primary indicator of the segment's financial health and value creation.
Ask your AI about Elevance Health's carelonrx — reportable segments’ operating gain.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude